Gapping down
In reaction to earnings/guidance:
- GTLB -30%, HEAR -11.2% (also extends repurchase program), GETY -10.6%, UAL -4.6% (guidance), SAVE -1.2% (guidance)
Other news:
- INVA -2.6% (announces FDA Advisory Committee meeting to review Sulbactam-Durlobactam)
- CS -2.4% (concluded that this material weakness could result in misstatements of account balances or disclosures that would result in a material misstatement to the annual financial statements)
- LQDT -1.1% (authorizes $8 mln for repurchases)
- CRSP -0.9% (hires new CFO)
Analyst comments:
- LU -0.5% (downgraded to Underperform from Neutral at Macquarie)
- OVV -0.5% (downgraded to Neutral from Overweight at JP Morgan)
